TY - JOUR
T1 - Eye-related quality of life and activities of daily living in pediatric retinoblastoma patients
T2 - A single-center, non-controlled, cross-sectional analysis
AU - Wise, Jacob
AU - Hayashi, Robert
AU - Wu, Tiffany
AU - Malone, Sara
AU - Badawi, Amer Al
AU - King, Allison
AU - Gordon, Mae
AU - Kimera, Lawrencia
AU - Lueder, Gregg
AU - Reynolds, Margaret
N1 - Publisher Copyright:
© 2023 Wiley Periodicals LLC.
PY - 2023/8
Y1 - 2023/8
N2 - Introduction: Childhood retinoblastoma (RB) survivors are known to experience long-term morbidity; however, eye-related quality of life (QoL), which may significantly impact activities of daily living (ADL), has not been extensively studied in this population. The purpose of this cross-sectional study was to assess QoL and ADL morbidity among school-age RB survivors. Methods: The Pediatric Eye Questionnaire (PedEyeQ) and Roll Evaluation Activities of Life (REAL) were administered to childhood RB survivors between ages 5 and 17 followed at St. Louis Children's Hospital. Visual outcomes and demographic predictors of ADL and QoL were examined. Results: Total 23 patients (mean age 9.6 years) consented for participation in this study. All children experienced at least one domain on the PedEyeQ ≤ 80%. Subjects and parents marked functional vision to be the most impacted domain with a median score of 82.5 and 83.4, respectively. Only 10.5% of participants scored above 75% on the ADL percentile rank. On multivariable analysis, decreased visual acuity (VA) was associated with worse “Child Functional” (odds ratio [OR] −59.2, p =.004) and “Parent Worry Function” (OR −66.5, p =.03) metrics. Decreased contrast sensitivity was associated with worse “Parent Impact” (OR 21.0, p =.02) and “Parent Worry Function” (OR 3.70, p =.04) metrics. Longer saccade horizontal latency was associated with a worse “Parent Worry Function” metric (OR 43.0, p =.009). On multivariable analysis, no variable was significantly associated with ADL. Conclusion: RB survivors have impaired QoL and ADL. Screening for such difficulties should strongly be considered for all RB patients. Additional studies may help predict morbidity based on visual metrics and demographic data.
AB - Introduction: Childhood retinoblastoma (RB) survivors are known to experience long-term morbidity; however, eye-related quality of life (QoL), which may significantly impact activities of daily living (ADL), has not been extensively studied in this population. The purpose of this cross-sectional study was to assess QoL and ADL morbidity among school-age RB survivors. Methods: The Pediatric Eye Questionnaire (PedEyeQ) and Roll Evaluation Activities of Life (REAL) were administered to childhood RB survivors between ages 5 and 17 followed at St. Louis Children's Hospital. Visual outcomes and demographic predictors of ADL and QoL were examined. Results: Total 23 patients (mean age 9.6 years) consented for participation in this study. All children experienced at least one domain on the PedEyeQ ≤ 80%. Subjects and parents marked functional vision to be the most impacted domain with a median score of 82.5 and 83.4, respectively. Only 10.5% of participants scored above 75% on the ADL percentile rank. On multivariable analysis, decreased visual acuity (VA) was associated with worse “Child Functional” (odds ratio [OR] −59.2, p =.004) and “Parent Worry Function” (OR −66.5, p =.03) metrics. Decreased contrast sensitivity was associated with worse “Parent Impact” (OR 21.0, p =.02) and “Parent Worry Function” (OR 3.70, p =.04) metrics. Longer saccade horizontal latency was associated with a worse “Parent Worry Function” metric (OR 43.0, p =.009). On multivariable analysis, no variable was significantly associated with ADL. Conclusion: RB survivors have impaired QoL and ADL. Screening for such difficulties should strongly be considered for all RB patients. Additional studies may help predict morbidity based on visual metrics and demographic data.
KW - activities of daily living
KW - contrast sensitivity
KW - quality of life
KW - retinoblastoma
KW - visual acuity
UR - http://www.scopus.com/inward/record.url?scp=85161421270&partnerID=8YFLogxK
U2 - 10.1002/pbc.30479
DO - 10.1002/pbc.30479
M3 - Article
C2 - 37269496
AN - SCOPUS:85161421270
SN - 1545-5009
VL - 70
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
IS - 8
M1 - e30479
ER -